Denali Therapeutics (DNLI) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Denali Therapeutics (DNLI) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Denali Therapeutics | 4.37 Bn | 4.37 Bn | - | -383.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -383.43% |
| Dec 31, 2025 | -2.42% |
| Sep 30, 2025 | -8.01% |
| Jun 30, 2025 | 93.13% |
| Mar 31, 2025 | -19.11% |
| Dec 31, 2024 | 5.18% |
| Sep 30, 2024 | -4.80% |
| Jun 30, 2024 | -166.21% |
| Mar 31, 2024 | -4.52% |
| Dec 31, 2023 | -34.99% |
| Sep 30, 2023 | -9.89% |
| Jun 30, 2023 | 368.85% |
| Mar 31, 2023 | -58.76% |
| Dec 31, 2022 | -19.41% |
| Sep 30, 2022 | -13.41% |
| Jun 30, 2022 | 4.84% |
| Mar 31, 2022 | 9.55% |
| Dec 31, 2021 | -130.58% |
| Sep 30, 2021 | -37.92% |
| Jun 30, 2021 | -1,153.83% |